Neuropathix

Neuropathix, Inc. | Breakthrough Therapeutics Targeting Inflammation

[Neuropathix @neuropathix]

@Neuropathix subsidiary @Kannalife Awarded $2.97 Million Grant from National Institute of Neurological Disorders and Stroke (NINDS)

$NPTX #NPTX #Neuropathix #Kannalife #KLS13019 #Grant #NIH #NINDS #HEALInitiative #SpotlightOnPainResearch #PainMonth2021

https://t.co/yykW3VsQZh

[Neuropathix @neuropathix]

Exciting news! Join @Neuropathix CEO Dean Petkanas at the 7th CB1, CB2, & Cannabinoid Drug Development Summit in Boston, Nov 18-20!

Don’t miss insights on #Cannabinoids #PeripheralNeuropathy #Neuroscience #MedicalResearch #Innovation #GPCR #GPR55 #CIPN

https://t.co/42QCks98hO

[Neuropathix @neuropathix]

Join @neuropathix CEO Dean Petkanas at the 7th CB1, CB2, & Cannabinoid Drug Development Summit November 18-20, 2024 | Boston, MA hosted by @HansonWade

#kannalife #gpcr #gpr55 #nlrp3 #ncx1 #kls13019 #neuro #inflammation #mitochondria

https://t.co/42QCks98hO

[Informationsdienst Wissenschaft - Nachrichten @idw_online_de]

1,4 Mio € von @MichaelJFoxOrg für Chi Wang Ip @Uniklinikum_Wue & Partnern @Kannalife #Atuka. Sie untersuchen am spez. Mausmodell, ob KLS-13019, das strukturell mit Cannabinoiden verwandt ist, ein wirksames Medikament gegen #Parkinson sein könnte.
https://t.co/wQwvsU4b3F

[Kannalife @Kannalife]

@Kannalife featured in @parkinsonstory - @MichaelJFoxOrg $1.49M grant to advance preclinical research into #KLS13019 - #Parkinsons #ParkinsonsResearch #Neuroinflammation #MitochondrialDysfunction #CannabinoidTherapeutic #Kannalife #MJFF

https://t.co/23GASI1c3b

[Kannalife @Kannalife]

@Kannalife secures $1.49M from @MichaelJFoxOrg for #ParkinsonsResearch! This funding will boost the development of #KLS13019, addressing #neuroinflammation and #mitochondrialdysfunction.

#Biotech #Innovation #CannabinoidTherapeutics #Kannalife #MJFF

https://t.co/jeblhRkKcW

[Kannalife @Kannalife]

@Kannlife CEO Dean Petkanas interview at @IAmBiotech #BIO2024 by Life Science Success Podcast #neuroprotection #cannabinoidtherapeutics #nlrp3 #gpcr #gpr55 #mitochondria #ncx1 #antiinflammatory

https://t.co/ynKYCiHcYU

[Kannalife @Kannalife]

@Kannalife selected by @NIH as one of 30 Companies to present at @BIOConvention in San Diego. Presentation Tues June 4, 2024 @ 4:30 PM in Company Presentation Theater 3. Plus visit us NIH booth #825 on Tues June 4 @ 11:56 AM #BIO #NIH #Kannalife #Biotech

https://t.co/mwMyfbUORF

[Neuropathix @neuropathix]

Exciting times @BioNJ_Org 🧬 Dean Petkanas of @Neuropathix @Kannalife sees New Jersey as the ultimate hub for life sciences. With 50% of attendees agreeing, NJ proves it's a leader in biotech! @ROINJNews #BioNJ #LifeSciences #Biotech #Pharma #Innovation

https://t.co/hTzALg8jXV

[Kannalife @Kannalife]

@Kannalife #Research Alert! Uncovering link between #KLS13019 & #GPR55 receptor - promising role in reducing #inflammation from chemotherapy-induced #peripheralneuropathy.

#Cannabinoid #Innovation #GPCR #CIPN #NeuroPain #Mitochondria

https://t.co/ZQn36rj5f1

[Neuropathix @neuropathix]

Dean Petkanas CEO of @Neuropathix @Kannalife presenting “#KLS13019 - A Remarkable #NonOpioid Drug Discovery for the #Treatment of #NeuroPain” -
Tune in on April 2, 2024 @ 11:30am EST / 8:30am PST - https://t.co/RjmKxzWnPK

[Neuropathix @neuropathix]

Join @Neuropathix at the 2023 @LifeSciSummit by @NIH on Oct 11, 2023 and see our subsidiary @Kannalife selected to take the stage at the Alexandria Center for Life Science in NYC

Learn more: https://t.co/Hsw22wMdL4

#Kannalife #Neuropathix #LifeSciSummit #Biotech #Innovation

[Neuropathix @neuropathix]

Today is the 12 year anniversary of founding @Neuropathix subsidiary @kannalife.

$NPTX #NPTX #Neuropathix #Kannalife #KLS13019 #Grant #NIH #NINDS #HEALInitiative #SpotlightOnPainResearch #pain #nonopioid #opioidalternative #cannabidiol #cbd

https://t.co/Hb2SNNjykv

[Neuropathix @neuropathix]

@Neuropathix CEO Dean Petkanas Interview on #ConciergeforBetterLiving with @DocRob

$NPTX #NPTX #Neuropathix #Kannalife #KLS13019 #cbd #cannabidiol #nonopioid #opioidcrisis #neuropathicpain #pain #painmanagement #NIH #HEALInitiative #opioidalternative

https://t.co/9727hduwOK

[Neuropathix @neuropathix]

@AAOA_tweets @ncl_tweets https://t.co/Z4TgpgiRys

[Neuropathix @neuropathix]

@nonopioidchoice https://t.co/Z4TgpgiRys

[Neuropathix @neuropathix]

Time to end this crisis now!

[Neuropathix @neuropathix]

@Neuropathix CEO Dean Petkanas pens Op-Ed on Why Opioids controlled the Pain Management Market and What's Next.

$NPTX #NPTX #Neuropathix #KLS13019 #Kannalife #opioids #opioidcrisis #pain #painmanagement #nonopioids #NIH #NINDS #HEALInitiative

https://t.co/Z4TgpgiRys

[Neuropathix @neuropathix]

@FixOpioidCrisis https://t.co/Z4TgpgiRys

[Neuropathix @neuropathix]

@OpioidCrisis__ https://t.co/Z4TgpgiRys

[Neuropathix @neuropathix]

@OCRFund https://t.co/Z4TgpgiRys